Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres (Q44794986)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2004
edit
Language Label Description Also known as
English
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres
scientific article published in April 2004

    Statements

    Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres (English)
    Ralph G Zinner
    Bonnie S Glisson
    Katherine M W Pisters
    Merril S Kies
    Pamela M Lee
    Bradley Sabloff
    Herbert A Fritsche
    Jae Y Ro
    Nelson G Ordonez
    Hai T Tran
    Ying Yang
    Terry L Smith
    Robert D Mass
    1 April 2004
    99-110

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit